搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
pharmaphorum
11 小时
Research shows NHS, industry partnership benefits patients
A new report commissioned by the Association of the British Pharmaceutical Industry (ABPI) has found that hospitals engaging ...
pharmaphorum
1 小时
Changing Faces – Digital and supplier hires for September 2024
HALIX, a Dutch contract development and manufacturing organisation (CDMO) specialising in complex therapeutic antibodies and ...
pharmaphorum
1 小时
AI pathology accelerates with Proscia Concentriq launch
During pilot programmes, Concentriq Embeddings demonstrated its ability to significantly accelerate AI development. In one ...
pharmaphorum
15 小时
Revisionist history on healthcare at the VP debate
In the third, final, and by most reckonings most inconsequential, national debate of the US presidential election, vice ...
pharmaphorum
1 天
Blue Shield of California bypasses PBMs to slash Humira prices by 90%
Starting January 1, 2025, most Blue Shield commercial members using Fresenius Kabi's adalimumab-aacf (a Humira biosimilar) ...
pharmaphorum
1 天
Amgen to face investor lawsuit over $10.7bn tax liability disclosure
The lawsuit, originally filed by the Roofers Local No. 149 Pension Fund in 2023, alleges that Amgen misled shareholders by ...
pharmaphorum
1 天
FDA issues summary of grants, promotes rare disease research
Seven new clinical trial grants were awarded under the Orphan Product Grants Program during the fiscal year (FY) 2024, ...
pharmaphorum
2 天
Ensuring compliance - The Functional Point of Contact (FPOC) story
A functional point of contact (FPOC) is a dedicated liaison in each functional area responsible for evaluating and ...
pharmaphorum
1 天
J&J's 340B rebate scheme stymied by strong-arm HRSA letter
The month-long standoff between the US Health Resources and Services Administration (HRSA) and Johnson & Johnson came to an ...
pharmaphorum
2 天
Genentech buys Regor's next-gen CDK inhibitors for $850M
Cambridge, Massachusetts-based biotech Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors for the ...
pharmaphorum
2 天
Changing Faces – Pharma and biotech September 2024
UCB taps new UK head. Belgium-based global biopharmaceutical company UCB welcomed Nico Reynders as its new general manager ...
pharmaphorum
2 天
Chiesi Biotech Center of Excellence opens to strengthen R&D in Italy
Chiesi’s strategy aligns with EU priorities on innovation, security, and private R&D investment: the decision to establish a ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈